Fundraising Fox

ProQR

Leiden, NL · 3 known investors

Find your way into ProQR

ProQR develops medicines for patients with unmet medical needs, focusing on therapeutic development in biotech.

BiotechHealthtechMedical Devices

Investors · 3

Invivo Capital PartnersBarcelona · $2.2M – $4.3M
Pontifax Venture CapitalHerzeliya · $6.3M – $128M
Sofinnova PartnersParis · $540K – $27M

In the news

ProQR Establishes First Clinical Validation Of Axiomer Platform; AX-0811 Data Due By Year-Endrttnews.com · Aug 2026BofA Securities initiates ProQR stock with buy on liver therapy By Investing.cominvesting.com · Aug 2026Bank of America Initiates Coverage on ProQR Therapeutics (NASDAQ:PRQR) - Ticker Reporttickerreport.com · Aug 2026HC Wainwright Expects Lower Earnings for ProQR Therapeuticsmarketbeat.com · Aug 2026ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement - The Globe and Mailtheglobeandmail.com · Jun 2026ProQR raises $50M as Lilly joins a $9.2M share buystocktitan.net · Jun 2026

Frequently asked questions

What does ProQR do?
ProQR develops medicines for patients with unmet medical needs, focusing on therapeutic development in biotech.
Who are ProQR's investors?
ProQR's investors include Invivo Capital Partners, Pontifax Venture Capital, Sofinnova Partners.
Where is ProQR headquartered?
ProQR is headquartered in Leiden, NL.